Hainan Huluwa Pharmaceutical Group Co.,Ltd.’s Net Profit Rose 13.1% in First Half of 2022

Hainan Huluwa Pharmaceutical Group Co.,Ltd. (海南葫芦娃药业集团股份有限公司) (605199.SH) reported a net profit of 57.3 million yuan in the first half of 2022, up 13.1% year-on-year.

Meanwhile, the company posted 733.5 million yuan in revenue, up 16.2% year-on-year.

At the end of the reporting period, it had 1.8 billion yuan in total assets and 809.6 million yuan in total liabilities, with a liability-to-asset ratio of 45%.